Idarucizumab administration in emergency situations: the Munich Registry of Reversal of Pradaxa ® in clinical routine (MR REPAIR)
ConclusionIn our study, we have shown that the administration of Idarucizumab is a rare intervention and restricted to patients with severe bleeding complications or ischemic stroke. The clinical outcome of patients who received Idarucizumab in emergency situations was poor.
Source: Journal of Neurology - Category: Neurology Source Type: research
More News: Bleeding | Brain | Emergency Medicine | Gastroenterology | Gastroschisis Repair | Ischemic Stroke | Laboratory Medicine | Neurology | Neurosurgery | Orthopaedics | Pradaxa | Stroke | Study